Search Results

ONX-0914 (PR-957) Evaluation Sample  | 98.11%

APEXBIO TECHNOLOGY LLC

Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

ONX-0914 (PR-957)

ONX-0914 (PR-957) 5mg  | 98.11%

APEXBIO TECHNOLOGY LLC

Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

ONX-0914 (PR-957)

ONX-0914 (PR-957) 10mg  | 98.11%

APEXBIO TECHNOLOGY LLC

Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

ONX-0914 (PR-957)

ONX-0914 (PR-957) 50mg  | 98.11%

APEXBIO TECHNOLOGY LLC

Immunoproteasome inhibitor,potent and selective Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

ONX-0914 (PR-957)

CEP-18770 5mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

CEP-18770

CEP-18770 10mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

CEP-18770

CEP-18770 50mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

CEP-18770

CEP-18770 100mg  | 98.02%

APEXBIO TECHNOLOGY LLC

Proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

CEP-18770

Salinosporamide A (NPI-0052, Marizomib) 100ug  | 95%

APEXBIO TECHNOLOGY LLC

20S proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

Salinosporamide A (NPI-0052, Marizomib)

CEP-18770 10mM (in 1mL DMSO)  | 98.02%

APEXBIO TECHNOLOGY LLC

Proteasome inhibitor Ubiquitination/ Proteasome|Proteasome

More Information Supplier Page

×

CEP-18770